Attention Deficit Hyperactivity Disorder (ADHD) is a reasonably common
developmental disorder that affects neurodevelopment. It often occurs alongside
other psychiatric and transitional conditions, such as depression, anxiety, and
oppositional disorder. This mix of conditions makes it harder to diagnose ADHD
correctly and manage it effectively. Coexisting issues can hide the main symptoms
of ADHD and require complicated treatment plans. This integrated review
combines current pharmacologic and non-pharmacologic strategies.
Pharmacological medications, including efficacy and safety profiles, such as
stimulants and non-stimulants, offer crucial symptomatic relief. Their efficacy and
safety profiles are often discussed, as well as their subtle use in different comorbid
situations. The primary non-pharmacological strategies are Cognitive-Behavioral
Therapy, primarily for learning emotional regulation and healthy coping
mechanisms, and Parent Management Training, which teaches how to strengthen
and manage various problem behaviors. Effective management should be
implemented using multidisciplinary models that involve various professionals,
with psychiatrists as the primary caregivers. It will also investigate how to use
artificial intelligence and big data for better care. Finally, a combined treatment
supported by research has great potential to improve the quality of life for children
and adolescents with ADHD and other conditions, as well as their overall academic
and work performance. Although some progress has been made, challenges in
diagnosis and therapy still exist. Further studies are needed to investigate the
effects of this approach.
Keywords: ADHD, comorbidity, child and adolescent psychiatry, medication,
therapy